(Q39142027)

9 September 2017

title

Intensive design in evaluating anxiolytic agents (English)

1 reference

16 March 2022

1 reference

16 March 2022

author name string

E. H. Uhlenhuth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A15297

16 March 2022

D. A. Turner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A15297

16 March 2022

G. Purchatzke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A15297

16 March 2022

T. Gift

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A15297

16 March 2022

J. Chassan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A15297

16 March 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15297

16 March 2022

publication date

1 March 1977

1 reference

9 September 2017

23 March 1977

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15297

16 March 2022

number of pages

7

1 reference

full work available at URL

inferred from page(s)

http://link.springer.com/content/pdf/10.1007/BF00426604.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00426604/fulltext.html

16 March 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF00426604

16 March 2022

1 reference

16 March 2022

1 reference

9 September 2017

volume

52

1 reference

9 September 2017

issue

1

1 reference

9 September 2017

page(s)

79-85

1 reference

A SINGLE-PATIENT, SELF-CONTROLLED AND SELF-RECORDED TRIAL OF WY 3498.

9 September 2017

cites work

1 reference

12 December 2020

Drug-Personality Interaction in Intensive Outpatient Treatment

1 reference

12 December 2020

Sample size in psychiatric drug research

1 reference

12 December 2020

Anxiety in schizophrenia. The responses to chlordiazepoxide in an intensive design study

1 reference

12 December 2020

AN APPROACH TO THE EVALUATION OF DRUG EFFECT DURING PSYCHOTHERAPY: A DOUBLE-BLIND STUDY OF A SINGLE CASE

1 reference

12 December 2020

The assessment of anxiety states by rating

1 reference

12 December 2020

A personality scale of manifest anxiety.

1 reference

12 December 2020

Reduction in symptomatology in ambulatory patients. The combined effects of a tranquilizer and psychotherapy.

1 reference

12 December 2020

Intensive design in medical research

1 reference

12 December 2020

The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory

1 reference

12 December 2020

The power of IMPS in psychiatric drug research: as a function of sample size, number of raters, and choice of treatment comparison

1 reference

12 December 2020

Psychiatric drug research. Sample size requirements for one vs two raters

1 reference

12 December 2020

Part 2. Improvement criteria in drug trials with neurotic patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00426604

1 reference

9 September 2017

1 reference